Anagliptin, A Dipeptidyl Peptidase-4 Inhibitor Ameliorates Arterial Stiffness in Association with Reduction of Remnant-Like Particle Cholesterol and Alanine Transaminase Levels in Type 2 Diabetic Patients. (Q50937252)
Jump to navigation
Jump to search
scientific article published on 24 June 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anagliptin, A Dipeptidyl Peptidase-4 Inhibitor Ameliorates Arterial Stiffness in Association with Reduction of Remnant-Like Particle Cholesterol and Alanine Transaminase Levels in Type 2 Diabetic Patients. |
scientific article published on 24 June 2016 |
Statements
1 reference
Anagliptin, A Dipeptidyl Peptidase-4 Inhibitor Ameliorates Arterial Stiffness in Association with Reduction of Remnant-Like Particle Cholesterol and Alanine Transaminase Levels in Type 2 Diabetic Patients. (English)
1 reference
Nobuhiro Tahara
1 reference
Sho-Ichi Yamagishi
1 reference
Munehisa Bekki
1 reference
Norihiro Kodama
1 reference
Tomohisa Nakamura
1 reference
Yoichi Sugiyama
1 reference
Tamami Oshige
1 reference
Yuki Kumashiro
1 reference
Akihiro Honda
1 reference
Atsuko Tahara
1 reference
Sachiyo Igata
1 reference
Yoshihiro Fukumoto
1 reference
24 June 2016
1 reference
14
1 reference
552-562
1 reference
6
1 reference
Identifiers
1 reference